|Articles|March 3, 2014
- Pharmaceutical Commerce - March/April 2014
CMS posts Sunshine Act registration details
Advertisement
On Feb. 7, CMS posted a notice that it will begin accepting registrations for Sunshine Act aggregate-spending reports from industry on Feb. 18.
Articles in this issue
over 11 years ago
The pharma rep profession will be immortalover 11 years ago
Six factors driving new specialty pharmaciesover 11 years ago
Common misconceptions about the orphan drug designationover 11 years ago
So you are 'in the cloud;' now what?over 11 years ago
Network effect of industry-crowdsourced physician dataover 11 years ago
Make your CRM vendor a true partner to your sales teamover 11 years ago
New adverse-events reporting service speeds results to payersover 11 years ago
Acquisitions realign UK logistics services, cold chain packagingover 11 years ago
After a relatively flat year, 2014 could be big for pharma M&ANewsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Pharma Pulse: Amazon Enters Weight-Loss Drug Market, Merck Expands US Manufacturing, and FDA Approves Tezspire for Chronic Sinusitis
2
Merck Begins Construction on $3 Billion Pharmaceutical Center of Excellence in Virginia
3
Frontier Scientific Solutions, ATSG Partner to Launch Air Network for Temperature-Controlled Pharmaceuticals
4
The Hidden Costs of Specialty Drug Access and Patient Loneliness
5
